Missouri Department of Economic Development (DED) Director David Kerr visited Kansas City International Airport (KCI) today and awarded nearly $7 million in state economic incentives to Jet Midwest Airlines, assisting the ... Read More
The Missouri Department of Economic Development (DED) announced today that a Kearney location has been designated as the state’s third Certified Site. Chosen by DED’s Certified Site team, the site will ... Read More
Gallagher North America Inc. has moved its U.S. headquarters from Sanford, Fla., to North Kansas City. The company, formerly Gallagher Security Management Systems, said in a release late Monday that the ... Read More
French drug giant Sanofi-Aventis Thursday said it will further expand its diabetes business with an exclusive worldwide licensing deal with CureDM Group Holdings LLC for the U.S.-based biotech’s experimental treatment Pancreate. ... Read More
Baxter International Inc. and Nycomed said Tuesday the Food and Drug Administration approved the surgical sealant TachoSil, which is used to control blood loss. TachoSil is manufactured and patented by Nycomed, ... Read More
A new partnership aimed at saving billions of dollars and accelerating sales of pollution-light electric cars was created by Renault, Nissan and Daimler, the companies announced on April 7. The companies ... Read More
Washington University School of Medicine in St. Louis said Tuesday it landed a five-year, $3.8 million federal grant for a center that helps researchers collect and use data on the brain ... Read More
Handmark Inc. is helping Freedom Communications Inc. develop mobile device applications for its group of newspapers and television stations. The Kansas City-based software company said in a release Tuesday that it ... Read More
Federal-Mogul Corp. is looking to acquire companies developing emerging technologies for electric vehicles, its CEO said. CEO José Maria Alapont told Crain’s that Southfield-based Federal-Mogul is in talks to acquire at ... Read More
Medical technology company CareFusion Corp. said Monday it will buy Medegen for $225 million in cash. Medegen makes needleless access valves and other products that deliver intravenous medication to patients. CareFusion ... Read More